Acute pancreatitis in children with inflammatory bowel disease: Risk factors, clinical course, and prognosis

Adi Anafy,Yehoshua Mirkin,Tut Galai,Amir Ben‐Tov,Hadar Lev‐Moran,Anat Yerushalmy‐Feler,Shlomi Cohen,Achiya Z. Amir
DOI: https://doi.org/10.1002/jpn3.12279
2024-06-06
Journal of Pediatric Gastroenterology and Nutrition
Abstract:Objectives To characterize the clinical course of acute pancreatitis (AP) in pediatric inflammatory bowel disease (IBD) patients compared to children with AP without IBD and to identify risk factors associated with AP among IBD patients. Methods This retrospective, single‐center study compared clinical characteristics of children ( 0.01), all had a mild pancreatitis, and none required invasive intervention. The presumed etiology for AP in all IBD patients was IBD‐related: IBD flare‐up in five, side effects of medications in two, and undetermined in seven. The only risk factor for AP development among IBD patients was IBD‐associated arthritis (23% vs. 3% for IBD‐non‐AP, p = 0.04), while extracolonic Crohn's disease and induction therapy with nutrition were negative risk factors (15% vs. 51%, p = 0.05, and 8% vs. 44%, p = 0.04, respectively). Other parameters, including disease type and medications, were nonsignificant. Conclusion The clinical course of AP in pediatric IBD patients is mild. Only IBD‐associated arthritis emerged as a risk factor for the development of AP, while, unexpectedly, IBD medication did not.
pediatrics,gastroenterology & hepatology,nutrition & dietetics
What problem does this paper attempt to address?